Sina Rosenkranz

Sina Rosenkranz studied medicine at the Universities of Hamburg, Pretoria, Berlin and Campeche, receiving her MD in 2014. She completed her neurology training at the University of Hamburg and conducted her postdoctoral training at the Institute of Neuroimmunology and Multiple Sclerosis (INIMS) at the UKE and the Cardiovascular Research Center at the Massachusetts General Hospital (MGH) and the Harvard Medical School in Boston. Since 2023, she has been the research group leader of the research group „Behavioral intervention in neuroimmunology“ at the INIMS. Since 2025, she has been a consultant neurologist and head of the Multiple Sclerosis (MS) Outpatient Clinic at the UKE. Her scientific work focuses on the neuroprotective potential of exercise and high altitude hypoxia in MS. Within the FOR 5705 her interest lies in the impact of inflammation on hippocampal neurogenesis.

Publications

The exercise hormone irisin has neuroprotective effects in a mouse model of multiple sclerosis. Rosenkranz S.C., da Rocha J.F., Moreira L. et al. Nat Metab. 8, 1051-1066 (2026).

Twelve-week intermittent hypoxia intervention in multiple sclerosis - A safety and feasibility trial. Schubert C., Suling A., Ramien C. et al. Mult Scler Relat Disord. 110, 107176 (2026).

The MoxFo initiative-Mechanisms of action: Biomarkers in multiple sclerosis exercise studies. Rosenkranz S.C., Ploughman M., Hvid L.G. et al. Mult Scler. 29, 1569-1577 (2023).

Visual function resists early neurodegeneration in the visual system in primary progressive multiple sclerosis. Rosenkranz S.C., Gutmann L., Has Silemek A.C. et al. J Neurol Neurosurg Psychiatry. 94, 924-933 (2023).

Enhancing mitochondrial activity in neurons protects against neurodegeneration in a mouse model of multiple sclerosis. Rosenkranz S.C., Shaposhnykov A.A., Träger S. et al. Elife. 10, e61798 (2021).

Links

Institute of Neuroimmunology and Multiple Sclerosis

Institution